Hepatitis-B-virus-related fibrosing cholestatic hepatitis after renal transplantation with acute graft failure following interferon-α therapy

Nephrology Dialysis Transplantation

Volumn 13, Issue 6, 1998, Pages 1574-1576

  Muñoz De Bustillo, Eduardo ^a   Ibarrola, Carolina ^a   Andrés, Amalo ^a   Colina, Francisco ^a   Morales, José M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Fibrosing cholestatic hepatitis; Graft failure; Hepatitis B virus; Interferon ; Renal transplantation

Indexed keywords

ALPHA INTERFERON; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CREATININE; CYCLOSPORIN; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN; STEROID; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; GRAFT FAILURE; HEPATITIS B VIRUS; HUMAN; KIDNEY TRANSPLANTATION; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; ACUTE KIDNEY FAILURE; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DEATH; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPEPSIA; FIBROSING CHOLESTATIC HEPATITIS; FLU LIKE SYNDROME; HEMODIALYSIS; HEPATITIS B; HUMAN TISSUE; HYPERTRANSAMINASEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; LIVER NECROSIS; MALAISE; RENAL GRAFT DYSFUNCTION; VIRUS PNEUMONIA;

ACUTE DISEASE; ADULT; CHOLESTASIS, INTRAHEPATIC; GRAFT REJECTION; HEPATITIS B; HUMANS; IMMUNOSUPPRESSION; INTERFERON-ALPHA; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; MALE; RECURRENCE;

EID: 0031746299     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.6.1574     Document Type: Article

References (17)

1. Fang JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in a patient with HIV and hepatitis B. Lancet 1993; 342: 1175
2. Davies SE, Portmann BC, O'Grady JG et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150-157
3. Benner KG, Lee RG, Keeffe EB, Lopez RR, Sasaki AW, Pinson CW. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992; 103: 1307-1312
4. Fang JWS, Tung FYT, Davis GL, Dolson DJ, Van Thiel DH, Lau JYN. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. Gastroenterology 1993; 105: 901-904
5. Mason AL, Wick M, White HM et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993; 105: 237-244
6. Chen CH, Chen PJ, Chu JS, Yeh KH, Lai MY, Chen DS. Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. Gastroenterology 1994; 107: 1514-1518
7. Angus PW, Locarnini SA, McCaughan GW, Jones RM, McMillan JS, Bowden DS. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 1995; 21: 14-18
8. Hung YB, Liang JT, Chu JS, Chen KM, Lee CS. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis. Hepatogastroenterology 1995; 42: 913-918
9. Lam PWY, Wachs ME, Somberg KA, Vincent F, Lake JR, Ferrel LD. Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation 1996; 61: 378-381
10. Feray C, Samuel D, Gigou M et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation. Antiviral effects and risk of rejection. Hepatology 1995; 22: 1084-1089
11. Rostaing L, Modesto A, Baron B, Cisterne JM, Chabannier MH, Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 1996; 74: 512-516
12. Ornellas de Souza MH, Abdelhay E, Silva MJM et al. Late marrow allograft rejection following alpha interferon therapy for hepatitis in a patient with paroxysmal nocturnal hemoglobinuria. Bone Marrow Transplant 1992; 9: 495-497
13. Ozgur O, Boyaciogîu S, Telatar H, Haberal: M. Recombinant alpha interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant 1995; 10: 2104-2106
14. Lau JY, Bain VG, Smith HM, Alexander GJ, Williams R. Modulation of hepatitis: B viral antigen expression by immunosuppressive drugs in primary hepatocyte culture. Transplantation 1992; 53: 894-898
15. Cote PJ, Korba BE, Baldwin B et al. Cyclosporine A modulates the course of woodchuck hepatitis virus infection and induces chronicity. J Immunol 1991; 146: 3138-3144
16. Pol S, Cavalcanti R, Carnot F et al. Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis. Transplantation 1996; 61: 1774-1776
17. Ben-Ari Z, Shmueli D, Mor B, Shapira Z, Tur-Kaspa R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 1997; 63: 393-396